<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01047826</url>
  </required_header>
  <id_info>
    <org_study_id>RC09/128</org_study_id>
    <nct_id>NCT01047826</nct_id>
  </id_info>
  <brief_title>M.I.P.O. vs Intramedullary Nailing in Tibia Fractures</brief_title>
  <acronym>MINT</acronym>
  <official_title>Intramedullary Nailing vs. M.I.P.O. in Fractures of the Tibia a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>King Abdullah International Medical Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>King Abdullah International Medical Research Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators are comparing two methods of standard treatments in distal tibial
      fractures. locked plating (M.I.P.O. technique) with intramedullary nailing.

      the investigators are hypothesizing that M.I.P.O group is superior to nailing in fractures of
      the distal third of the tibia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The kind of plates the investigators are comparing are the Locked plates form Synthes ® using
      the minimally invasive technique vs the Expert Tibial Nail® from Synthes ®
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2010</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate Of Malunion</measure>
    <time_frame>6 months</time_frame>
    <description>Any healing that occurs with any one of the following:
More than 5 degree angulation in the anterior-posterior or lateral view or Rotation of more than 10 degrees or Shorting of more than 1 cm.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Short Form (12) Health Score (SF-12v2®)</measure>
    <time_frame>every 3 months till healing or 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Loss</measure>
    <time_frame>during the time of surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiation exposure</measure>
    <time_frame>During the time of Surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Surgery</measure>
    <time_frame>During the time of Surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infection Rate</measure>
    <time_frame>every 3 months till healing or 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Stay</measure>
    <time_frame>After Surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time Of Fracture Healing</measure>
    <time_frame>6 months</time_frame>
    <description>Clinical Criteria: No pain or tenderness while wight bearing or palpating the fracture site
Radiological Criteria: Bridging of the fracture site in anterior-posterior and lateral views.
Using these two criteria we well be able to measure the time of healing in our study subjects.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Tibia Fracture</condition>
  <arm_group>
    <arm_group_label>M.I.P.O. Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subjects who have been randomized to the M.I.P.O. group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intramedullary Nail group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects who have been Randomized to the I.M. group</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Minimally Invasive Plate Osteosynthesis</intervention_name>
    <description>Fractures well be treated with locked plates using M.I.P.O. Technique</description>
    <arm_group_label>M.I.P.O. Group</arm_group_label>
    <other_name>Minimally invasive percutaneous plate osteosynthesis (MIPPO)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>intramedullary tibial Nailing</intervention_name>
    <description>Fractures well be fixed using intramedullary nails</description>
    <arm_group_label>Intramedullary Nail group</arm_group_label>
    <other_name>Expert Tibial Nail ®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and Females aged from 18-60 years

          -  Closed Tibia Fracture

          -  Tibia Fracture Müller AO Class 43-A

        Exclusion Criteria:

          -  Intra-articular Fractures

          -  Open fractures

          -  fracturesSubjects with documented Marfan's syndrome or Ehlers-Danlos syndrome or
             Hajdu-Cheney syndrome.

          -  Post organ transplant patients (except Cornea transplant)

          -  Subjects on immunosuppressive medications

          -  Subjects with diagnosed with

               -  Osteogenesis imperfecta

               -  Osteopetrosis

               -  Paget disease of bone

               -  Renal osteodystrophy

          -  Subjects with diagnosed neoplasms or mitotic illnesses

          -  Subjects receiving growth hormone

          -  Unable to comply with postoperative rehabilitation e.g. head injury

          -  Impending compartment syndrome
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Husam A AL-Rumaih, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Guard Heath Affaires, Saudi Arabia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wael S Taha, MD</last_name>
    <role>Study Director</role>
    <affiliation>National Guard Health Affairs</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sami I AL-Essia, MD</last_name>
    <role>Study Chair</role>
    <affiliation>National Guard Health Affairs</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Husam A AL-Rumaih, MD</last_name>
    <phone>+96612520088</phone>
    <phone_ext>14119</phone_ext>
    <email>rumaih@me.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Wael S Taha, MD</last_name>
    <phone>+96612520088</phone>
    <phone_ext>14117</phone_ext>
    <email>waelstaha@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>King Abdullah International Medical Research Center</name>
      <address>
        <city>Riyadh</city>
        <state>Central</state>
        <zip>11426</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Husam A AL-Rumaih, MD</last_name>
      <phone>+96612520088</phone>
      <phone_ext>14119</phone_ext>
      <email>rumaih@me.com</email>
    </contact>
    <contact_backup>
      <last_name>Sami I AL-Essia, MD</last_name>
      <phone>+96612520088</phone>
      <phone_ext>14119</phone_ext>
      <email>saleissa@yahoo.com</email>
    </contact_backup>
    <investigator>
      <last_name>Wael S Taha, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Abdulaziz AL-Ammari, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Saudi Arabia</country>
  </location_countries>
  <link>
    <url>http://www.kaimrc.med.sa/</url>
    <description>King Abdullah International Medical Research Center</description>
  </link>
  <link>
    <url>http://www.minttrial.com</url>
    <description>The Trials webpage</description>
  </link>
  <verification_date>October 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 12, 2010</study_first_submitted>
  <study_first_submitted_qc>January 12, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 13, 2010</study_first_posted>
  <last_update_submitted>June 22, 2011</last_update_submitted>
  <last_update_submitted_qc>June 22, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 23, 2011</last_update_posted>
  <responsible_party>
    <name_title>Husam A. AL-Rumaih/Dr</name_title>
    <organization>King Abdullah International Medical Research Center</organization>
  </responsible_party>
  <keyword>Fractured Tibia</keyword>
  <keyword>Expert Tibial Nail</keyword>
  <keyword>Minimally Invasive Plate Osteosynthesis (M.I.P.O)</keyword>
  <keyword>Intramedullary Nailing</keyword>
  <keyword>Locked Plate</keyword>
  <keyword>distal third</keyword>
  <keyword>43-A</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Tibial Fractures</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

